These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19736844)

  • 1. Aminoglycoside-induced hearing loss: South Africans at risk.
    Bardien S; de Jong G; Schaaf HS; Harris T; Fagan J; Petersen L
    S Afr Med J; 2009 Jun; 99(6):440-1. PubMed ID: 19736844
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides.
    Human H; Hagen CM; de Jong G; Harris T; Lombard D; Christiansen M; Bardien S
    Biochem Biophys Res Commun; 2010 Mar; 393(4):751-6. PubMed ID: 20171168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenetic heterogenicity of ototoxic complications caused by aminoglycoside antibiotics].
    Zhuravskiĭ SG; Setkhiiaasiilan T; Dekhtiareva IuA
    Vestn Otorinolaringol; 2005; (1):62-5. PubMed ID: 15700018
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention].
    Lautermann J; Schacht J; Jahnke K
    HNO; 2003 Apr; 51(4):344-51; quiz 352. PubMed ID: 12682739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ototoxic drugs. I. Aminoglycoside antibiotics].
    Buszman E; Wrześniok D; Matusiński B
    Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review.
    Bindu LH; Reddy PP
    Int J Audiol; 2008 Nov; 47(11):702-7. PubMed ID: 19031229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.
    O'Donnell EP; Scarsi KK; Scheetz MH; Postelnick MJ; Cullina J; Jain M
    Int J Antimicrob Agents; 2010 Jul; 36(1):94-5. PubMed ID: 20382508
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes.
    Veenstra DL; Harris J; Gibson RL; Rosenfeld M; Burke W; Watts C
    Genet Med; 2007 Oct; 9(10):695-704. PubMed ID: 18073583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis.
    Vasconcelos KA; Frota SMMC; Ruffino-Netto A; Kritski AL
    Rev Soc Bras Med Trop; 2017; 50(5):646-651. PubMed ID: 29160511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation and mitochondrial DNA sequence analysis in two Chinese families with aminoglycoside-induced and non-syndromic hearing loss.
    Zhao L; Wang Q; Qian Y; Li R; Cao J; Hart LC; Zhai S; Han D; Young WY; Guan MX
    Biochem Biophys Res Commun; 2005 Oct; 336(3):967-73. PubMed ID: 16168391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hearing and the vestibular function in pulmonary tuberculosis during antibacterial therapy].
    Miasnikov VG; Mishchanchuk NS
    Probl Tuberk; 1980 Nov; (11):38-42. PubMed ID: 6969886
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
    Hong H; Dowdy DW; Dooley KE; Francis HW; Budhathoki C; Han HR; Farley JE
    Am J Audiol; 2020 Jun; 29(2):199-205. PubMed ID: 32320639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
    Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.
    Heysell SK; Ahmed S; Rahman MT; Akhanda MW; Gleason AT; Ebers A; Houpt ER; Banu S
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29348152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of hearing in patients with multiresistant tuberculosis].
    Ribeiro L; Sousa C; Sousa A; Ferreira C; Duarte R; Faria E Almeida A; Condé A
    Acta Med Port; 2015; 28(1):87-91. PubMed ID: 25817503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylcysteine in the prevention of ototoxicity.
    Tepel M
    Kidney Int; 2007 Aug; 72(3):231-2. PubMed ID: 17653228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in aminoglycoside therapy and ototoxicity.
    Xie J; Talaska AE; Schacht J
    Hear Res; 2011 Nov; 281(1-2):28-37. PubMed ID: 21640178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?
    May ML; Osowicki J; Gaafar D; Suthers G
    J Paediatr Child Health; 2023 Jan; 59(1):9-11. PubMed ID: 36465032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutational screening of the mitochondrial 12S rRNA gene in Polish patients with aminoglycoside-induced hearing loss].
    Rydzanicz M
    Otolaryngol Pol; 2011; 65(4):297-9. PubMed ID: 22000150
    [No Abstract]   [Full Text] [Related]  

  • 20. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.
    Schacht J; Talaska AE; Rybak LP
    Anat Rec (Hoboken); 2012 Nov; 295(11):1837-50. PubMed ID: 23045231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.